Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fuss Brands Corp. (FBDS : OTC)

• Company Description    FUSS BRANDS INC. engages in the research, manufacture and distribution of botanical products, bio-pharmaceutical products and traditional Chinese medicines. Its products include Siberian ginseng, other plant-based anti-depression and nerve regulation products, botanical antibiotics, badger oil and ginseng and deer antler extracts. FUSS BRANDS INC., formerly known as China Botanic Pharmaceutical Inc., is based in New York. Number of Employees: 1

• Price / Volume Information    Yesterday's Closing Price: $0.55 Daily Weekly Monthly 20 Day Moving Average: 43 shares Shares Outstanding: 21.45 (millions) Market Capitalization: $11.80 (millions) Beta: -3.95 52 Week High: $0.55 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1,122.22% 1,076.45% 12 Week 5,400.00% 4,526.23% Year To Date 9,900.00% 9,264.97%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 80 BROAD STREET 5TH FLOOR - NEW YORK,NY 10036 USA ph: 917-720-3366 fax: 86-451-5760-4764 ir@renhuang.com http://www.fussbrands.com

• General Corporate Information    Officers Cheskel Meisels - Chief Executive Officer; Treasurer; and Secretary Weiqiu Dong - Chief Financial Officer Zack Pan - Director Bingchun Wu - Director Changxiong Sun - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 16890Y203 SIC: 2834 Fiscal Year Fiscal Year End: October Last Reported Quarter: 04/01/25 Next Expected EPS Date: 09/05/25 Share - Related Items Shares Outstanding: 21.45 Most Recent Split Date: 7.00 (0.04:1) Beta: -3.95 Market Capitalization: $11.80 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/05/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 100.00% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 04/30/25 - - 01/31/25 - - 10/31/24 - - ROA 04/30/25 - -74.17 01/31/25 - -1,267.89 10/31/24 - -1,360.33 Current Ratio 04/30/25 - 0.23 01/31/25 - 0.23 10/31/24 - 0.25 Quick Ratio 04/30/25 - 0.23 01/31/25 - 0.23 10/31/24 - 0.25 Operating Margin 04/30/25 - - 01/31/25 - - 10/31/24 - - Net Margin 04/30/25 - - 01/31/25 - - 10/31/24 - - Pre-Tax Margin 04/30/25 - - 01/31/25 - - 10/31/24 - - Book Value 04/30/25 - -0.04 01/31/25 - -0.04 10/31/24 - -0.04 Inventory Turnover 04/30/25 - - 01/31/25 - - 10/31/24 - - Debt-to-Equity 04/30/25 - - 01/31/25 - - 10/31/24 - - Debt-to-Capital 04/30/25 - - 01/31/25 - - 10/31/24 - -

Powered by Zacks Investment Research ©